Skip to main content
Investigational lupus drug cenerimod moves to phase 3 studies after equivocal phase 2 results
Primary tabs
•••
View
Get Stamp Tags
Published Locations
Breadcrumb
Home
Investigational lupus drug cenerimod moves to phase 3 studies after equivocal phase 2 results
User login
Username
Password
Reset your password
Concept
Lead
score
Systemic Lupus Erythematosus
1
1
Lupus
0
0.9
Lupus Nephritis
0
0.61
Receptors
0
0.33
Hypertension
0
0.17
Multiple Sclerosis
0
0.14
Blood
0
0.08
Calcium
0
0.08
Central Nervous System
0
0.08
Hospital
0
0.08
Infestations
0
0.08
Leukopenia
0
0.08
Lymph Node
0
0.08
Multiple Sclerosis Treatment
0
0.08
Nephritis
0
0.08
Orbit
0
0.08
Osteoarthritis
0
0.08
Preventive Screening
0
0.08
Tissue
0
0.08
Transplant Evaluation
0
0.08
Specialty
Lead
score
Rheumatology
1
1
Allergy & Clinical Immunology
0
0.9
Edit Tags